BrightSpring Health Services/$BTSG

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About BrightSpring Health Services

BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services and others. It generates the majority of its revenue from the Pharmacy Solutions segment.

Ticker

$BTSG
Sector
Health Care
Primary listing
NASDAQ

Industry

Health Care Providers & Services
Headquarters
Louisville, United States

Employees

37,000

ISIN

US10950A1060
Website
www.brightspringhealth.com

BTSG Metrics

BasicAdvanced
$4.1B
80.80
$0.29
-
-

What the Analysts think about BTSG

Analyst ratings (Buy, Hold, Sell) for BrightSpring Health Services stock.

Bulls say / Bears say

BrightSpring Health Services reported a 25.9% year-over-year increase in net revenue for Q1 2025, reaching $2.878 billion, indicating strong growth momentum. (tradingview.com)
The company successfully refinanced its $2.55 billion Term Loan B facility, reducing the interest rate by 75 basis points and saving approximately $19.1 million annually in cash interest. (gurufocus.com)
BTIG Research raised its price target for BrightSpring Health Services from $15.00 to $20.00, maintaining a 'buy' rating, reflecting confidence in the company's future performance. (marketbeat.com)
BrightSpring Health Services has a high net debt to equity ratio of 146.7%, indicating significant leverage that could pose financial risks. (simplywall.st)
The company's debt is not well covered by operating cash flow, with a coverage ratio of only 8%, suggesting potential challenges in meeting debt obligations. (simplywall.st)
Interest payments on the company's debt are not well covered by EBIT, with a coverage ratio of 1.9x, indicating potential strain on earnings due to debt servicing. (simplywall.st)
Data summarised monthly by Lightyear AI. Last updated on 5 Jun 2025.

BTSG Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

BTSG Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

BTSG News

AllArticlesVideos
BrightSpring Health Services Announces Onco360® Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs

BrightSpring Health Services Announces Onco360® Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs

GlobeNewsWire·1 week ago
BrightSpring Announces Pricing of Secondary Offering of Common Stock

BrightSpring Announces Pricing of Secondary Offering of Common Stock

GlobeNewsWire·2 weeks ago
BrightSpring Announces Secondary Offering of Common Stock

BrightSpring Announces Secondary Offering of Common Stock

GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BTSG

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs